Impact of Executive and Adaptive function on Functional Outcomes in Adults with Maple Syrup Urine Disease
Gold, J. I.; Strong, A.; Gold, N. B.; Yudkoff, M.; Szalda, D.; Jan, S.; Schwartz, L. A.; Ganetzky, R.
Show abstract
PurposeSuccessful transition to adulthood requires intact executive and adaptive function. These neurocognitive domains, critical for independence, are frequently impaired in inherited metabolic disorders (IMD), though predictive clinical and biochemical factors are lacking. Standardized assessments linking neurocognitive status with functional outcomes are needed to improve prognostication and tailor support for affected emerging adults. MethodsMaple Syrup Urine Disease (MSUD), a relatively prevalent IMD, is primarily diagnosed in the first week of life through newborn screening. Despite early intervention, executive and adaptive dysfunction persist. We designed a remote, interactive battery of neurocognitive and functional assessments for adults ([≥]21 years) with MSUD to correlate neurocognition and long-term outcomes. ResultsAssessments completed by 28 adults with MSUD (23 diagnosed after symptom onset) show a wide range in educational attainment, employment, and residence. Executive function, and adaptive function were significantly impaired in adults with MSUD compared to controls. Executive and adaptive deficits correlated negatively with obtaining skills needed for adult-oriented healthcare or independent living. Clinical history did not predict functional outcomes, but neurocognitive assessments suggest the benefits of pre-symptomatic diagnosis. ConclusionIndependent adulthood is attainable for individuals with MSUD. Routine, targeted assessment of neurocognition may improve long-term functional outcomes in IMD.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Post-COVID sequelae in people with multiple sclerosis and related disorders: a multicenter cross-sectional study 92%
- Hybrid and vaccine-induced immunity against SARS-CoV-2 in MS patients on different disease-modifying therapies 89%
- Choroid plexus volume predicts expansion of chronic lesions and brain atrophy 89%
Similar papers in this journal
- GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study 92%
- Recognizing the Evolution of Clinical Syndrome Spectrum Progression in Individuals with Single Large-Scale mitochondrial DNA deletion syndromes (SLSMDS) 92%
- Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder 91%
Similar papers in this journal
- Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study 91%
- A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis 91%
- MS-driven metabolic alterations are recapitulated in iPSC-derived astrocytes 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.